FST and ovarian carcinoma: One plausible mechanism by which FST may exert its resistance-promoting effects is by creating an immune-cold TME (Figure 3B), as suggested by the negative enrichment of genes associated with inflammatory responses in ovarian cancer cells overexpressing FST [84].